We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$64.8B
AUM Growth
-$1.23B
Cap. Flow
+$395M
Cap. Flow %
0.61%
Top 10 Hldgs %
28.4%
Holding
1,116
New
212
Increased
277
Reduced
389
Closed
160

Top Sells

Rank Stock Value
1
RNAM
Avidity Biosciences
RNAM
+$190M
2
RPRX icon
Royalty Pharma
RPRX
+$187M
3
DOV icon
Dover
DOV
+$178M
4
BA icon
Boeing
BA
+$168M
5
DVN icon
Devon Energy
DVN
+$155M

Sector Composition

Rank Sector Weight
1 Technology 27.24%
2 Healthcare 15.45%
3 Financials 12.46%
4 Industrials 9.23%
5 Communication Services 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVAC
576
EQV Ventures Acquisition Corp II
EVAC
$598M
$15.1M 0.02%
1,500,000
FDMT icon
577
4D Molecular Therapeutics
FDMT
$526M
$14.9M 0.02%
1,605,156
+370,000
+30% +$3.22M
AXTA icon
578
Axalta
AXTA
$7.01B
$14.9M 0.02%
537,865
-872,704
-62% -$27.7M
QADRU
579
QDRO Acquisition Corp Units
QADRU
$14.9M 0.02%
+1,500,000
New +$14.9M
DD icon
580
DuPont de Nemours
DD
$18.6B
$14.7M 0.02%
106,700
-4,367
-4% -$602K
FFIV icon
581
F5
FFIV
$22.1B
$14.6M 0.02%
50,400
-1,700
-3% -$471K
LULU icon
582
lululemon athletica
LULU
$13B
$14.6M 0.02%
95,200
-12,200
-11% -$2.19M
VICI icon
583
VICI Properties
VICI
$29.4B
$14.5M 0.02%
532,500
-267,400
-33% -$7.65M
KMI icon
584
Kinder Morgan
KMI
$73.1B
$14.5M 0.02%
433,854
-393,600
-48% -$12.3M
LVS icon
585
Las Vegas Sands
LVS
$30.5B
$14.5M 0.02%
269,700
-5,000
-2% -$285K
ACRS icon
586
Aclaris Therapeutics
ACRS
$730M
$14.5M 0.02%
3,871,000
+500,000
+15% +$1.69M
AMCR icon
587
Amcor
AMCR
$20.6B
$14.4M 0.02%
362,198
-54,600
-13% -$2.41M
FN icon
588
Fabrinet
FN
$17.1B
$14.3M 0.02%
+27,500
New +$14M
GPN icon
589
Global Payments
GPN
$22.1B
$14.3M 0.02%
212,260
+8,600
+4% +$634K
AVB icon
590
AvalonBay Communities
AVB
$27.1B
$14.3M 0.02%
87,368
-18,118
-17% -$3.17M
ECHO
591
EchoStar
ECHO
$25.5B
$14.1M 0.02%
+120,100
New +$13.8M
KHC icon
592
Kraft Heinz
KHC
$30.4B
$14M 0.02%
622,432
-25,000
-4% -$588K
RKT icon
593
Rocket Companies
RKT
$36.9B
$13.9M 0.02%
+974,900
New +$17.7M
CBLL
594
CeriBell Inc
CBLL
$642M
$13.9M 0.02%
756,751
+256,751
+51% +$5.16M
TRMB icon
595
Trimble
TRMB
$12.3B
$13.8M 0.02%
212,222
-406,600
-66% -$28.3M
OVID icon
596
Ovid Therapeutics
OVID
$435M
$13.7M 0.02%
6,163,781
+2,671,781
+77% +$4.78M
FHN icon
597
First Horizon
FHN
$12.1B
$13.7M 0.02%
600,100
+150,207
+33% +$3.59M
TEAM icon
598
Atlassian
TEAM
$22B
$13.7M 0.02%
200,000
-50,000
-20% -$4.93M
TXT icon
599
Textron
TXT
$16.6B
$13.6M 0.02%
155,426
+86,300
+125% +$8.06M
IR icon
600
Ingersoll Rand
IR
$33B
$13.5M 0.02%
168,892
+134,300
+388% +$11.9M

Similar funds

Adage Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Adage Capital Partners held 1,116 positions worth $64.8B, down 1.9% from $66.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Adage Capital Partners's Q1 2026 filing shows 212 new, 277 increased, 389 reduced and 160 closed positions. Its largest new stake was Takeda Pharmaceutical: 6,424,984 shares worth $119M. The largest sale was Avidity Biosciences, an estimated $190M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q1 2026 buy was Takeda Pharmaceutical: 6,424,984 shares worth $119M.
  • Adage Capital Partners added most to Revolution Medicines in Q1 2026, an estimated $330M increase.
  • Adage Capital Partners's biggest Q1 2026 reduction was Royalty Pharma, cutting an estimated $187M.
  • Adage Capital Partners fully exited Avidity Biosciences in Q1 2026, selling an estimated $190M.
  • Adage Capital Partners's ten largest holdings make up 28% of its $64.8B portfolio in Q1 2026.
  • Adage Capital Partners opened 212 new positions and closed 160 in Q1 2026.
  • Adage Capital Partners's portfolio value fell 1.9% quarter-over-quarter to $64.8B.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.